ZIVO Bioscience
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
0.26-0.01-0.02-0.01-0.01-0.04-0.07-2.32-2.68-0.26N/A-0.01
Price/Sales ratio
N/AN/AN/AN/AN/AN/A38.07N/AN/A73.34N/AN/A
Price/Book Value ratio
-0.02-0.01-0.01-0.00-0.01-0.07-0.063.61-2.21K-0.91N/A-0.01
Price/Cash Flow ratio
-0.06-0.04-0.06-0.03-0.05-0.15-0.29-3.21-3.30-0.34N/A-0.05
Price/Free Cash Flow ratio
-0.06-0.04-0.06-0.03-0.05-0.15-0.29-3.21-3.30-0.34N/A-0.05
Price/Earnings Growth ratio
-0.000.00-0.01-0.00-0.000.000.000.060.100.01N/A-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A100%N/AN/A41.98%N/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A-42778.37%N/AN/A-26267.67%N/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A-45528.64%N/AN/A-28127.24%N/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A-48278.91%N/AN/A-28127.24%N/AN/A
Effective Tax Rate
-763.25%-31.64%-23.15%-16.57%-2.78%-27.43%-6.04%-2.54%N/AN/AN/A-2.78%
Return on Assets
668.39%-7965.23%-821.87%-238.43%-3556.53%-3970.83%-4385.42%-104.52%-411.92%-1399.49%-411.92%-3556.53%
Return On Equity
-10.68%60.95%44.48%61.56%65.68%175.90%85.36%-155.51%82331.88%352.57%-384.04%175.90%
Return on Capital Employed
84.03%62.39%33.41%1804.89%27.51%100.16%76.56%-149.82%-9162.90%329.26%-9162.90%100.16%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.93N/A
Quick Ratio
0.000.000.040.070.010.040.013.030.930.150.880.01
Cash ratio
0.000.000.040.060.010.030.013.010.880.090.880.01
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A49.30N/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A49.30N/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A26.52KN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A-26.47KN/AN/A
Debt Ratios
Debt Ratio
39.3384.7613.984.2344.1114.2924.120.020.110.431.0014.29
Debt Equity Ratio
-0.62-0.64-0.75-1.09-0.81-0.63-0.460.03-22.59-0.10-200.86-0.63
Long-term Debt to Capitalization
-0.03-0.93-0.30-45.48N/AN/A-0.01N/AN/AN/AN/AN/A
Total Debt to Capitalization
-1.69-1.84-3.1111.63-4.39-1.72-0.880.031.04-0.12N/A-4.39
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-655.60N/A
Cash Flow to Debt Ratio
-0.68-0.37-0.24-0.23-0.27-0.70-0.48-28.34-29.59-24.16N/A-0.27
Company Equity Multiplier
-0.01-0.00-0.05-0.25-0.01-0.04-0.011.48-199.86-0.25-199.86-0.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A-129.42N/AN/A-209.76N/AN/A
Free Cash Flow / Operating Cash Flow Ratio
111111111111
Cash Flow Coverage Ratio
-0.68-0.37-0.24-0.23-0.27-0.70-0.48-28.34-29.59-24.16N/A-0.27
Short Term Coverage Ratio
-0.72-1.47-0.35-2.25-0.27-0.70-0.49-28.34-29.59-24.16N/A-0.27
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A